Although more research is needed, researchers suggest that trauma centers may benefit from monitoring COVID patients for additional complications and screening.
Although more research is needed, researchers suggest that trauma centers may benefit from monitoring COVID patients for additional complications and screening.
Even without symptoms, trauma patients who test positive for COVID fare worse than comparable patients who do not have virus miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Alexion, AstraZeneca’s Rare Disease group, has closed an exclusive global collaboration and licence agreement with Neurimmune AG for NI006, an investigational human monoclonal antibody currently in Phase Ib development for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM), an underdiagnosed, systemic .